Amgen Inc Stock EBITDA

AMGN Stock  USD 286.30  4.53  1.61%   
Amgen Inc fundamentals help investors to digest information that contributes to Amgen's financial success or failures. It also enables traders to predict the movement of Amgen Stock. The fundamental analysis module provides a way to measure Amgen's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Amgen stock.
As of the 28th of March 2024, EBITDA is likely to drop to about 5.2 B.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Amgen EBITDA Analysis

Amgen's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

Amgen Ebitda

5.16 Billion

EBITDA

 = 

Revenue

-

Basic Expenses

More About EBITDA | All Equity Analysis

Current Amgen EBITDA

    
  7.9 B  
Most of Amgen's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Amgen Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Amgen EBITDA Driver Correlations

Understanding the fundamental principles of building solid financial models for Amgen is extremely important. It helps to project a fair market value of Amgen Stock properly, considering its historical fundamentals such as EBITDA. Since Amgen's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Amgen's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Amgen's interrelated accounts and indicators.
0.740.330.94-0.40.78-0.190.470.910.520.260.810.370.770.160.910.810.810.480.49-0.450.820.390.560.570.270.08-0.30.55
0.74-0.370.85-0.880.99-0.210.840.94-0.07-0.060.88-0.290.540.270.910.610.710.750.55-0.870.75-0.020.680.650.07-0.33-0.810.83
0.33-0.370.070.66-0.290.17-0.51-0.090.790.36-0.110.880.36-0.16-0.040.290.06-0.45-0.140.590.050.6-0.28-0.170.220.470.69-0.38
0.940.850.07-0.530.89-0.320.680.970.270.170.80.160.590.160.980.70.790.710.41-0.570.770.240.760.580.190.1-0.420.76
-0.4-0.880.66-0.53-0.820.13-0.74-0.70.330.11-0.760.62-0.43-0.34-0.63-0.47-0.52-0.59-0.530.95-0.570.34-0.46-0.480.040.60.94-0.66
0.780.99-0.290.89-0.82-0.170.840.96-0.04-0.040.84-0.230.530.250.950.640.710.780.48-0.810.73-0.010.760.620.08-0.2-0.730.86
-0.19-0.210.17-0.320.13-0.17-0.2-0.270.06-0.26-0.28-0.010.05-0.08-0.230.18-0.35-0.45-0.240.28-0.26-0.22-0.2-0.32-0.190.10.24-0.22
0.470.84-0.510.68-0.740.84-0.20.73-0.31-0.250.59-0.420.180.40.750.360.480.750.2-0.70.52-0.120.710.44-0.13-0.19-0.650.86
0.910.94-0.090.97-0.70.96-0.270.730.180.110.890.010.630.220.980.710.810.720.55-0.720.810.150.720.660.18-0.11-0.610.78
0.52-0.070.790.270.33-0.040.06-0.310.180.50.220.890.61-0.130.160.510.41-0.40.350.330.450.52-0.090.240.420.350.42-0.35
0.26-0.060.360.170.11-0.04-0.26-0.250.110.50.050.470.32-0.180.030.20.26-0.180.260.090.130.18-0.10.060.860.050.12-0.22
0.810.88-0.110.8-0.760.84-0.280.590.890.220.05-0.050.760.210.820.710.790.540.71-0.80.850.210.430.70.13-0.4-0.720.59
0.37-0.290.880.160.62-0.23-0.01-0.420.010.890.47-0.050.26-0.330.030.20.11-0.40.060.610.110.56-0.120.070.40.560.68-0.32
0.770.540.360.59-0.430.530.050.180.630.610.320.760.260.280.570.920.750.030.59-0.450.810.270.120.40.22-0.23-0.330.11
0.160.27-0.160.16-0.340.25-0.080.40.22-0.13-0.180.21-0.330.280.210.30.350.170.15-0.40.37-0.210.060.09-0.33-0.33-0.310.13
0.910.91-0.040.98-0.630.95-0.230.750.980.160.030.820.030.570.210.70.770.750.41-0.650.770.160.790.580.090.03-0.520.82
0.810.610.290.7-0.470.640.180.360.710.510.20.710.20.920.30.70.740.160.39-0.440.780.150.370.310.070.0-0.280.28
0.810.710.060.79-0.520.71-0.350.480.810.410.260.790.110.750.350.770.740.510.63-0.620.950.30.560.60.24-0.04-0.480.34
0.480.75-0.450.71-0.590.78-0.450.750.72-0.4-0.180.54-0.40.030.170.750.160.510.2-0.690.420.010.810.46-0.03-0.04-0.630.85
0.490.55-0.140.41-0.530.48-0.240.20.550.350.260.710.060.590.150.410.390.630.2-0.560.680.040.140.830.41-0.47-0.590.13
-0.45-0.870.59-0.570.95-0.810.28-0.7-0.720.330.09-0.80.61-0.45-0.4-0.65-0.44-0.62-0.69-0.56-0.630.18-0.44-0.530.020.620.96-0.64
0.820.750.050.77-0.570.73-0.260.520.810.450.130.850.110.810.370.770.780.950.420.68-0.630.260.470.670.12-0.13-0.50.36
0.39-0.020.60.240.34-0.01-0.22-0.120.150.520.180.210.560.27-0.210.160.150.30.010.040.180.26-0.050.060.330.180.23-0.07
0.560.68-0.280.76-0.460.76-0.20.710.72-0.09-0.10.43-0.120.120.060.790.370.560.810.14-0.440.47-0.050.4-0.010.36-0.360.71
0.570.65-0.170.58-0.480.62-0.320.440.660.240.060.70.070.40.090.580.310.60.460.83-0.530.670.060.40.25-0.24-0.550.41
0.270.070.220.190.040.08-0.19-0.130.180.420.860.130.40.22-0.330.090.070.24-0.030.410.020.120.33-0.010.25-0.05-0.03-0.07
0.08-0.330.470.10.6-0.20.1-0.19-0.110.350.05-0.40.56-0.23-0.330.030.0-0.04-0.04-0.470.62-0.130.180.36-0.24-0.050.71-0.13
-0.3-0.810.69-0.420.94-0.730.24-0.65-0.610.420.12-0.720.68-0.33-0.31-0.52-0.28-0.48-0.63-0.590.96-0.50.23-0.36-0.55-0.030.71-0.59
0.550.83-0.380.76-0.660.86-0.220.860.78-0.35-0.220.59-0.320.110.130.820.280.340.850.13-0.640.36-0.070.710.41-0.07-0.13-0.59
Click cells to compare fundamentals

Amgen EBITDA Historical Pattern

Today, most investors in Amgen Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Amgen's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's ebitda growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Amgen ebitda as a starting point in their analysis.
   Amgen EBITDA   
       Timeline  
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Competition

Amgen Ebitda

Ebitda

5.16 Billion

At this time, Amgen's EBITDA is very stable compared to the past year.
According to the company disclosure, Amgen Inc reported earnings before interest,tax, depreciation and amortization of 7.9 B. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The ebitda for all United States stocks is 102.57% lower than that of the firm.

Amgen EBITDA Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Amgen's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Amgen could also be used in its relative valuation, which is a method of valuing Amgen by comparing valuation metrics of similar companies.
Amgen is currently under evaluation in ebitda category among related companies.

Amgen ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Amgen's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Amgen's managers, analysts, and investors.
Environment Score
Governance Score
Social Score

Amgen Institutional Holders

Institutional Holdings refers to the ownership stake in Amgen that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Amgen's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Amgen's value.
Shares
Northern Trust Corp2023-12-31
6.4 M
Royal Bank Of Canada2023-12-31
5.8 M
Bank Of New York Mellon Corp2023-12-31
5.5 M
Norges Bank2023-12-31
5.4 M
Legal & General Group Plc2023-12-31
M
Fmr Inc2023-12-31
4.8 M
Bank Of America Corp2023-12-31
4.3 M
Aristotle Capital Management Llc2023-12-31
4.2 M
Jpmorgan Chase & Co2023-12-31
M
Vanguard Group Inc2023-12-31
49 M
Blackrock Inc2023-12-31
47.8 M

Amgen Fundamentals

About Amgen Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Amgen Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Amgen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Amgen Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for 2024
EBITDA7.9 B5.2 B

Pair Trading with Amgen

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amgen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amgen will appreciate offsetting losses from the drop in the long position's value.

Moving together with Amgen Stock

  0.62MBIO Mustang Bio Report 3rd of April 2024 PairCorr

Moving against Amgen Stock

  0.76EQ Equillium Financial Report 9th of May 2024 PairCorr
  0.73TCRX Tscan Therapeutics Financial Report 8th of May 2024 PairCorr
  0.65DNLI Denali Therapeutics Financial Report 13th of May 2024 PairCorr
  0.6VANI Vivani Medical Report 29th of March 2024 PairCorr
  0.56MDGL Madrigal Pharmaceuticals Financial Report 14th of May 2024 PairCorr
The ability to find closely correlated positions to Amgen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amgen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amgen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amgen Inc to buy it.
The correlation of Amgen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amgen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amgen Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Amgen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Amgen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amgen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amgen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amgen Inc Stock:
Check out Amgen Piotroski F Score and Amgen Altman Z Score analysis.
Note that the Amgen Inc information on this page should be used as a complementary analysis to other Amgen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Complementary Tools for Amgen Stock analysis

When running Amgen's price analysis, check to measure Amgen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amgen is operating at the current time. Most of Amgen's value examination focuses on studying past and present price action to predict the probability of Amgen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amgen's price. Additionally, you may evaluate how the addition of Amgen to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
CEOs Directory
Screen CEOs from public companies around the world
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Is Amgen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amgen. If investors know Amgen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amgen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.52)
Dividend Share
8.52
Earnings Share
12.48
Revenue Per Share
52.692
Quarterly Revenue Growth
0.198
The market value of Amgen Inc is measured differently than its book value, which is the value of Amgen that is recorded on the company's balance sheet. Investors also form their own opinion of Amgen's value that differs from its market value or its book value, called intrinsic value, which is Amgen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amgen's market value can be influenced by many factors that don't directly affect Amgen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amgen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Amgen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amgen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.